KAW letter to FDA critiquing a possible growth promoter only ban in the United States.

FDA is asking drug manufacturers to voluntarily withdraw growth and efficiency claims for antimicrobials, and to voluntarily modify all other claims so that they can be used only under veterinary oversight. KAW believes that this approach may require considerable effort on the part of FDA while having very little impact on public health